WARPTECHNEWS · LAB

Home AI Business Tech Archive

Fulcrum lays off majority of staff; Seres extends runway into 2027 — Warptech Lab News

Fulcrum lays off majority of staff; Seres extends runway into 2027

Fulcrum Therapeutics cuts 84% of staff after halting sickle cell drug; Seres extends cash runway to Q1 2027 via $25M Nestlé deal.

venerdì 5 giugno 2026 New tab

41 words~1 min read

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Confirm Endpoints as a trusted biopharma news source

Bioscience & Technology Business Center

The University of Kansas

Lawrence, Kansas

Other newsrooms on this story

· 6 sources

Full timeline →

biopharmadive.com·Jun 2, 2026 · 1 mese fa
Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug
economictimes.indiatimes.com·Jun 2, 2026 · 1 mese fa
US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concerns
benzinga.com·Jun 4, 2026 · 1 mese fa
What's Going On With Fulcrum Therapeutics Stock On Thursday? - Fulcrum Therapeutics (NASDAQ:FULC)
benzinga.com·Jun 2, 2026 · 1 mese fa
FULC Stock Crashes After Hours: What Investors Need To Know - Fulcrum Therapeutics (NASDAQ:FULC)
statnews.com·Jun 2, 2026 · 1 mese fa
Radiopharmaceutical shows promise in post-Pluvicto setting
biopharmadive.com·Jun 10, 2026 · 1 mese fa
AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine

Related reading

Fulcrum ends sickle cell ambitions following regulatory feedback, will seek exit

Fulcrum Therapeutics is scrapping its sole clinical-stage medicine, pociredir for sickle cell disease, after feedback from the…

endpoints.news·1 mese fa

Design Therapeutics' Friedreich ataxia data; Vincentage's obesity results from…

Design Therapeutics shares Phase 1/2 data in Friedreich ataxia; Vincentage Pharma, a new China obesity player, emerges with Phase…

endpoints.news·2 mesi fa

Achieve Life Sciences gets a CRL; UPS invests $48M in healthcare logistics

Achieve Life Sciences gets FDA CRL for cytisinicline; UPS puts $48M into cold-chain logistics; AdvanCell is establishing a US…

endpoints.news·1 mese fa

Novo Nordisk expands in China and Czech; Cellares boosts Series D by $50M

Novo Nordisk invests ~$380M in Czech manufacturing and $29.4M in China; Cellares grows Series D to $327M; Eisai gets support;…

endpoints.news·1 mese fa

BMS eyes new campus in Texas; Novartis looks to evict tenant at Slovenian campus

Bristol Myers Squibb looks to Texas; Novartis looks to remove CDMO from its Slovenia campus; and more

endpoints.news·2 mesi fa

Sensorion axes hearing loss program; Novartis' biomarker data in muscular…

Sensorion selects one hearing loss program, axes another; Novartis hits biomarker endpoint for muscular dystrophy drug; J&J's…

endpoints.news·1 mese fa

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com